Bruker (BRKRP) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.19% |
| Dec 31, 2025 | 2.51% |
| Sep 30, 2025 | -19.16% |
| Jun 30, 2025 | -66.52% |
| Mar 31, 2025 | 13.18% |
| Dec 31, 2024 | 6.88% |
| Sep 30, 2024 | -6.03% |
| Jun 30, 2024 | -36.44% |
| Mar 31, 2024 | 8.95% |
| Dec 31, 2023 | 9.21% |
| Sep 30, 2023 | 9.91% |
| Jun 30, 2023 | -18.48% |
| Mar 31, 2023 | 14.84% |
| Dec 31, 2022 | 10.59% |
| Sep 30, 2022 | 14.51% |
| Jun 30, 2022 | -20.88% |
| Mar 31, 2022 | 19.00% |
| Dec 31, 2021 | 8.83% |
| Sep 30, 2021 | -7.81% |
| Jun 30, 2021 | 3.89% |
| Mar 31, 2021 | 55.18% |
| Dec 31, 2020 | 6.30% |
| Sep 30, 2020 | 8.78% |
| Jun 30, 2020 | 58.06% |
| Mar 31, 2020 | 5.33% |
| Dec 31, 2019 | 14.47% |
| Sep 30, 2019 | 31.16% |
| Jun 30, 2019 | -4.00% |
| Mar 31, 2019 | -5.15% |
| Dec 31, 2018 | 0.14% |
| Sep 30, 2018 | -6.51% |
| Jun 30, 2018 | 49.18% |
| Mar 31, 2018 | 34.53% |
| Dec 31, 2017 | 2.67% |
| Sep 30, 2017 | 159.50% |
| Jun 30, 2017 | -19.76% |
| Mar 31, 2017 | 46.69% |
| Dec 31, 2016 | -0.28% |
| Sep 30, 2016 | 11.11% |
| Jun 30, 2016 | 36.64% |
| Mar 31, 2016 | 13.79% |
| Dec 31, 2015 | 9.88% |
| Sep 30, 2015 | 41.31% |
| Jun 30, 2015 | -15.23% |
| Mar 31, 2015 | 37.47% |